Filana Therapeutics Inc (FLNA) Wheel Strategy

Running a FLNA wheel strategy lets you generate consistent premium income on Filana Therapeutics Inc while setting your own entry and exit prices on the underlying. Filana Therapeutics Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own FLNA, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best FLNA wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on FLNA, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable FLNA wheel from a losing one.

Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the FLNA wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your FLNA wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.